The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fungal Infection Diagnosis Market Research Report 2025
Synopsis
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
The global Fungal Infection Diagnosis market was valued at US$ 18 million in 2023 and is anticipated to reach US$ 30 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, accounting for more than 90% in 2019.
Among the two types of products, the galactomannan experiment accounts for the largest proportion, and in 2019, it accounts for about 60% of the market. The downstream application markets for the diagnosis of fungal infections are mainly hospitals, laboratories and others. Among them, hospitals accounted for the largest proportion.
This report aims to provide a comprehensive presentation of the global market for Fungal Infection Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Infection Diagnosis.
Report Scope
The Fungal Infection Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fungal Infection Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fungal Infection Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ASSOCIATES OF CAPE COD
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A & C Biological Ltd.
Segment by Type
Galactomannan Test
(1 to 3)-β-D-glucan Experiment
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fungal Infection Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
The global Fungal Infection Diagnosis market was valued at US$ 18 million in 2023 and is anticipated to reach US$ 30 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, accounting for more than 90% in 2019.
Among the two types of products, the galactomannan experiment accounts for the largest proportion, and in 2019, it accounts for about 60% of the market. The downstream application markets for the diagnosis of fungal infections are mainly hospitals, laboratories and others. Among them, hospitals accounted for the largest proportion.
This report aims to provide a comprehensive presentation of the global market for Fungal Infection Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Infection Diagnosis.
Report Scope
The Fungal Infection Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fungal Infection Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fungal Infection Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ASSOCIATES OF CAPE COD
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A & C Biological Ltd.
Segment by Type
Galactomannan Test
(1 to 3)-β-D-glucan Experiment
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fungal Infection Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fungal Infection Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Galactomannan Test
1.2.3 (1 to 3)-β-D-glucan Experiment
1.3 Market by Application
1.3.1 Global Fungal Infection Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fungal Infection Diagnosis Market Perspective (2019-2030)
2.2 Fungal Infection Diagnosis Growth Trends by Region
2.2.1 Global Fungal Infection Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fungal Infection Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Fungal Infection Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Fungal Infection Diagnosis Market Dynamics
2.3.1 Fungal Infection Diagnosis Industry Trends
2.3.2 Fungal Infection Diagnosis Market Drivers
2.3.3 Fungal Infection Diagnosis Market Challenges
2.3.4 Fungal Infection Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fungal Infection Diagnosis Players by Revenue
3.1.1 Global Top Fungal Infection Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Fungal Infection Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fungal Infection Diagnosis Revenue
3.4 Global Fungal Infection Diagnosis Market Concentration Ratio
3.4.1 Global Fungal Infection Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fungal Infection Diagnosis Revenue in 2023
3.5 Fungal Infection Diagnosis Key Players Head office and Area Served
3.6 Key Players Fungal Infection Diagnosis Product Solution and Service
3.7 Date of Enter into Fungal Infection Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fungal Infection Diagnosis Breakdown Data by Type
4.1 Global Fungal Infection Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Fungal Infection Diagnosis Forecasted Market Size by Type (2025-2030)
5 Fungal Infection Diagnosis Breakdown Data by Application
5.1 Global Fungal Infection Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Fungal Infection Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fungal Infection Diagnosis Market Size (2019-2030)
6.2 North America Fungal Infection Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fungal Infection Diagnosis Market Size by Country (2019-2024)
6.4 North America Fungal Infection Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fungal Infection Diagnosis Market Size (2019-2030)
7.2 Europe Fungal Infection Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fungal Infection Diagnosis Market Size by Country (2019-2024)
7.4 Europe Fungal Infection Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fungal Infection Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Fungal Infection Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fungal Infection Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Fungal Infection Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fungal Infection Diagnosis Market Size (2019-2030)
9.2 Latin America Fungal Infection Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fungal Infection Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Fungal Infection Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fungal Infection Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Fungal Infection Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fungal Infection Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Fungal Infection Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ASSOCIATES OF CAPE COD
11.1.1 ASSOCIATES OF CAPE COD Company Detail
11.1.2 ASSOCIATES OF CAPE COD Business Overview
11.1.3 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Introduction
11.1.4 ASSOCIATES OF CAPE COD Revenue in Fungal Infection Diagnosis Business (2019-2024)
11.1.5 ASSOCIATES OF CAPE COD Recent Development
11.2 BioRad
11.2.1 BioRad Company Detail
11.2.2 BioRad Business Overview
11.2.3 BioRad Fungal Infection Diagnosis Introduction
11.2.4 BioRad Revenue in Fungal Infection Diagnosis Business (2019-2024)
11.2.5 BioRad Recent Development
11.3 IMMY
11.3.1 IMMY Company Detail
11.3.2 IMMY Business Overview
11.3.3 IMMY Fungal Infection Diagnosis Introduction
11.3.4 IMMY Revenue in Fungal Infection Diagnosis Business (2019-2024)
11.3.5 IMMY Recent Development
11.4 Beijing Jinshanchuan
11.4.1 Beijing Jinshanchuan Company Detail
11.4.2 Beijing Jinshanchuan Business Overview
11.4.3 Beijing Jinshanchuan Fungal Infection Diagnosis Introduction
11.4.4 Beijing Jinshanchuan Revenue in Fungal Infection Diagnosis Business (2019-2024)
11.4.5 Beijing Jinshanchuan Recent Development
11.5 Danna Biological
11.5.1 Danna Biological Company Detail
11.5.2 Danna Biological Business Overview
11.5.3 Danna Biological Fungal Infection Diagnosis Introduction
11.5.4 Danna Biological Revenue in Fungal Infection Diagnosis Business (2019-2024)
11.5.5 Danna Biological Recent Development
11.6 Zhanjiang A & C Biological Ltd.
11.6.1 Zhanjiang A & C Biological Ltd. Company Detail
11.6.2 Zhanjiang A & C Biological Ltd. Business Overview
11.6.3 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Introduction
11.6.4 Zhanjiang A & C Biological Ltd. Revenue in Fungal Infection Diagnosis Business (2019-2024)
11.6.5 Zhanjiang A & C Biological Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
